1. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial;Lancet,2002
2. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, et al.. (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360: : 1623–1630. S014067360211600X [pii].
3. Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, et al.. (2001) Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285: : 1711–1718. joc10254 [pii].
4. Predicting response to statins by pharmacogenetic testing;IC Gelissen;Pharmacogenomics,2012
5. Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin;MW Medina;Circulation,2008